³ΙΘΛΏμΚΦ

header-logo
GettyImages-609179959-hero
headshot

Jeffrey Whittle, MD, MPH

Professor

view provider profile

Locations

  • Zablocki VA Medical Center
  • Zablocki VA Medical Center

Specialties

  • Internal Medicine

Languages

  • English

Education

  • MD - Doctor of Medicine
  • MPH - Master of Public Health

Biography

Jeffrey C. Whittle, MD, MPH, is a staff physician at the Clement J. Zablocki VA Medical Center and professor of medicine (general internal medicine). He attended the ³ΙΘΛΏμΚΦ then received his internal medicine residency training at the University of Alabama-Birmingham. After staying on a year as chief medical resident, he was a fellow in general medicine at the Johns Hopkins Medical Institutions, where he also received his Masters of Public Health. After ten years on the faculty at the University of Pittsburgh he became division director at the Kansas University Medical Center in September of 2001. He moved to the ³ΙΘΛΏμΚΦ in March of 2005.

Research Interests

Dr. Whittle's research has focused on access to care issues and quality of care. He is a national authority on the reasons for racial differences in cardiovascular procedure use. He has used a variety of methods, including analysis of Medicare and VA administrative data, studies of clinically defined cohorts, surveys, and chart reviews. His work has been funded by the Veterans Administration, National Institutes of Health, Agency for Healthcare Research and Quality, Health Services Resource Administration and American Heart Association.

Since joining CAPS, Dr. Whittle has developed an innovative community academic partnership with veteran community organizations including Vietnam Veterans of America, American Legion, Veterans of Foreign Wars and National Association of Black Veterans. This extends his work on access and quality to community-based effort to improve the quality of hypertension care for older individuals by empowering them to take an active role in their own health care. He is currently studying the effectiveness of this approach in a large randomized trial funded by the Department of Veterans Affairs Health Services Research and Development Service.

Publications

  • (Jacobson TA, Engel JS, Kandula V, Madkins K, Vassallo P, Puthumana J, Mehta CK, Allen BD, Whittle J.) Ann Thorac Surg. 2026 Sep 10 PMID: 42722267 09/10/2026

  • (Farzana S, Rossi FM, Luo QE, Whittle J, McGurk K, Weston BW, Yuan AY, Moghtaderi A, Atanasov V, Black BS.) Vaccines (Basel). 2026 Aug 20;14(8) PMID: 42646734 PMCID: PMC13517372 SCOPUS ID: 2-s2.0-105048735763 08/26/2026

  • (Rossi FM, Franchi L, Atanasov V, Barreto N, Whittle J, Meurer J, Weston B, McGurk K, Luo QE, Yuan A, Black B.) Am J Epidemiol. 2026 Jul 13 PMID: 42442708 07/14/2026

  • (Jackson JL, Kuriyama A, Whittle J, Davis-Maxwell A, Thompson M, Murphy MG, Gondi S, Brennan K, Ganshert C, Fletcher KE.) Ann Intern Med. 2026 Mar;179(3):382-393 PMID: 41525693 SCOPUS ID: 2-s2.0-105033105637 01/12/2026

  • (Rossi FM, Franchi L, Barreto N, Chorniy A, Weston BW, Meurer JR, Whittle J, Ackermann RT, Black B.) Med Care. 2026 Feb 01;64(2):77-88 PMID: 41433210 PMCID: PMC13286083 SCOPUS ID: 2-s2.0-105027098308 12/23/2025

  • (Hooyer K, Ertl K, Franco Z, Flower M, Miller J, Winstead O, Reynolds J, Fialkowski J, Rogers D, Wiedenkeller D, Cocroft J, Munoz C, Kummer K, Whittle J.) Journal of Participatory Research Methods. 2026;7(3) SCOPUS ID: 2-s2.0-105042529300 01/01/2026

  • (Farzana S, Rossi FM, Allen KS, Luo Q, Whittle J, McGurk K, Weston BW, Yuan AY, Moghtaderi A, Atanasov V, Black B.) Vaccines (Basel). 2025 Dec 11;13(12) PMID: 41441701 PMCID: PMC12737531 12/24/2025

  • (Mosher CL, Stebbins A, Lamberton CE, Wruck LM, Hernandez AF, Benziger CP, Whittle J, Gupta K, Rothman RL, Kripalani S, Kunisaki KM, Fawzy A, Dransfield MT, Jones WS.) J Am Heart Assoc. 2025 Dec 02;14(23):e043161 PMID: 41294093 PMCID: PMC12748523 SCOPUS ID: 2-s2.0-105024261173 11/26/2025

  • (Narcisse DI, Whittle J, Rhodes GM, Stebbins AL, Wruck LM, Mulder H, Kripalani S, Muñoz D, Effron MB, Gupta K, Handberg EM, Girotra S, Hess R, Benziger CP, Farrehi P, VanWormer JJ, Knowlton KU, Polonsky TS, Bradley SM, Robertson HR, Hammill BG, Rothman RL, Harrington RA, Jones WS, Hernandez AF.) Contemp Clin Trials. 2025 Sep;156:108030 PMID: 40716702 SCOPUS ID: 2-s2.0-105012410116 07/29/2025

  • (Oh H, Yang L, Zahra TA, Tian S, Park MS, Luo J, Ahamed SI, Chan E, Whittle J.) Proc COMPSAC. 2025 Jul;2025:1873-1878 PMID: 41058926 PMCID: PMC12498523 10/08/2025

  • (Farzana S, Rossi FM, Allen KS, Luo Q, Whittle J, McGurk K, Weston BW, Yuan AY, Moghtaderi A, Atanasov V, Black B.) Vaccines. December 2025;13(12) SCOPUS ID: 2-s2.0-105025937858 12/01/2025

  • (Oh H, Yang L, Zahra TA, Rabbani M, Tian S, Anik AA, Upama PB, Park MS, Luo J, Chan E, Whittle J, Ahamed SI.) AMIA Annu Symp Proc. 2024;2024:875-884 PMID: 40417574 PMCID: PMC12099394 SCOPUS ID: 2-s2.0-105006856809 05/26/2025

Publications of from the

© 2026 ³ΙΘΛΏμΚΦ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ³ΙΘΛΏμΚΦ (³ΙΘΛΏμΚΦ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ³ΙΘΛΏμΚΦ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

³ΙΘΛΏμΚΦ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ³ΙΘΛΏμΚΦ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.